BKIDC-1553
BKIDC-1553 is an orally active antiglycolytic agent and a bumped kinase inhibitor derived compound with a predicted ~17 h half-life in human. BKIDC-1553 inhibits CYP2C8 and Angiotensin Converting Enzyme and can be used for cancer research[1].
Product Specifications
CAS Number
[1951431-34-7]
UNSPSC
12352005
Target
Angiotensin-converting Enzyme (ACE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/bkidc-1553.html
Concentration
10mM
Purity
99.65
Solubility
DMSO : 20 mg/mL (ultrasonic)
Smiles
OC(C)(CN1N=C(C2=C1N=CN=C2N)C3=CC4=C(C=C(C=C4)OC5CC5)C=C3)C
Molecular Formula
C22H23N5O2
Molecular Weight
389.45
References & Citations
[1]Uo T, et al. A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer. bioRxiv [Preprint]. 2024 Feb 13:2023.07.01.547355.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
041647-APC 200 µL
SGCA, ID (SGCA, ADL, DAG2, Alpha-sarcoglycan, 50kD dystrophin-associated glycoprotein, Adhalin, Dystroglycan-2) (APC) discontinued
Ask
View Details